Page last updated: 2024-10-25

amphetamine and Wallerian Degeneration

amphetamine has been researched along with Wallerian Degeneration in 1 studies

Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.

Wallerian Degeneration: Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sajadi, A1
Schneider, BL1
Aebischer, P1

Other Studies

1 other study available for amphetamine and Wallerian Degeneration

ArticleYear
Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease.
    Current biology : CB, 2004, Feb-17, Volume: 14, Issue:4

    Topics: Amphetamine; Animals; Cell Survival; Disease Models, Animal; Dopamine; Immunohistochemistry; Mice; M

2004